The landscape of dementia prognosis has developed drastically with the arrival of subtle biomarkers, including amyloid PET scans, tau imaging, and blood-based tests which can detect Alzheimer's pathology years before signs and symptoms emerge. Although these technological improvements depict impressive progress in understanding neurodegenerative diseases, they have not diminished the https://mentalhealthassessmentofo11009.bloggazza.com/36943605/the-enduring-price-of-cognitive-evaluation-for-older-adults